Moreover, an inverse correlation between BCL2 expression and the apoptotic rate has been demonstrated in PTCL (13), and BCL2 overexpression in PTCLs seems to correlate with disease progression through interactions with the p53-dependent pathway (14). The gene discussed is BCL2; the disease is mature T-cell and NK-cell non-Hodgkin lymphoma.